PTPN1 and major depressive disorder: Circulating ceramide is significantly associated with MDD in clinical and preclinical models [93], mediated via ceramide acting on brain endothelial cells to inhibit phospholipase D (PLD), thereby suppressing phosphatidic acid and increasing hippocampal phosphotyrosine phosphatase (PTP1B).